Cisplatin is widely used in thoracic oncology. Its main limiting adverse effect is renal toxicity. A huge intravenous hydration is known to delivery administration of high-dose cisplatin at out-patient (OP) clinic using a shorter intravenous hydration protocol. However, the safety of this strategy has never been investigated yet. Here, we aimed to provide a comparative study of creatinine clearance levels changes in OP compared to the standard inpatient protocol (IP).
Citation: Couraud S, Coudurier M, Toffart AC, Destors M, Villar E, et al. (2015) Cisplatin Administration at Outpatient Clinics is Safe Compared to the In-Patient Usual Protocol: Findings from a Comparative Study. J Pulm Respir Med 5:262.